Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience

Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (31)

  1. A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy. 2025-01-01 · Expand citations
  2. Must Psilocybin Always "Assist Psychotherapy"? 2024-01-01 · Expand citations
  3. Group psychedelic therapy: empirical estimates of cost-savings and improved access. 2023-01-01 · Expand citations
  4. The economics of psychedelic-assisted therapies: A research agenda. 2022-01-01 · Expand citations
  5. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. 2019-10-24 · Expand citations
  6. Psychedelic-Assisted Group Therapy: A Systematic Review. 2019-01-01 · Expand citations
  7. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  8. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  9. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. 2016-12-01 · Expand citations
  10. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. 2015-11-01 · Expand citations
  11. 10.1002/cncr.30012
  12. 10.1002/cncr.30015
  13. 10.1016/j.jad.2018.09.027
  14. 10.1016/j.jmpt.2003.11.003
  15. 10.1016/j.jpainsymman.2014.04.012
  16. 10.1037/0022-3514.69.4.719
  17. 10.1038/s41591-025-03685-9
  18. 10.1080/13548506.2010.487107
  19. 10.1097/00008483-200311000-00001
  20. 10.1097/hcr.0000000000000379
  21. 10.1111/bjso.12006
  22. 10.1111/j.1600-0447.1983.tb09716.x
  23. 10.1177/0269881119855974
  24. 10.1177/28314425251404460.
  25. 10.1177/28314425251413856.
  26. 10.1200/jco.1993.11.3.570
  27. 10.1371/journal.pone.0207820
  28. 10.1556/2054.2019.015
  29. 10.3109/09540261.2013.842542
  30. 10.31234/osf.io/caup9_v2
  31. 10.3389/fphar.2021.623985

Cited by — these papers cite this paper (1)

  1. Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations